KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Other Operating Expenses (2016 - 2025)

Sarepta Therapeutics has reported Other Operating Expenses over the past 10 years, most recently at $399.4 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $399.4 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $842.2 million (up 1546.28% YoY), and the annual figure for FY2023 was $102.0 million, changed.
  • Other Operating Expenses for Q4 2025 was $399.4 million at Sarepta Therapeutics, up from $151.5 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for SRPT hit a ceiling of $399.4 million in Q4 2025 and a floor of $31.6 million in Q1 2022.
  • Median Other Operating Expenses over the past 5 years was $102.0 million (2021), compared with a mean of $119.7 million.
  • Peak annual rise in Other Operating Expenses hit 919.47% in 2021, while the deepest fall reached 69.91% in 2021.
  • Sarepta Therapeutics' Other Operating Expenses stood at $102.0 million in 2021, then crashed by 69.0% to $31.6 million in 2022, then surged by 222.57% to $102.0 million in 2023, then crashed by 49.84% to $51.2 million in 2024, then skyrocketed by 680.68% to $399.4 million in 2025.
  • The last three reported values for Other Operating Expenses were $399.4 million (Q4 2025), $151.5 million (Q3 2025), and $153.2 million (Q2 2025) per Business Quant data.